Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Koichiro Inaki

1PUBLICATIONS

17CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 16, 2024

The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer.

Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto

Pageof 1

Frequent Collaborators

1 joint publications

Shigehiro Koganemaru

1 joint publications

Shohei Koyama

1 joint publications

Fumitaka Suto

1 joint publications

Makito Koga

1 joint publications

Yusuke Kuwahara

1 joint publications

Takeo Arita

1 joint publications

Tsuyoshi Hirata

1 joint publications

Hiroki Goto

1 joint publications

Naoya Wada

1 joint publications

Maki Kobayashi

Frequent Collaborators

1 joint publications

Shigehiro Koganemaru

1 joint publications

Shohei Koyama

1 joint publications

Fumitaka Suto

1 joint publications

Makito Koga

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos